Title: ETX201: An experimental vectorized miRNA-based approach for the treatment of Angelman syndrome Presenter: Sirika Pillay, Ph.D., Director of Molecular and Cellular Pharmacology, Encoded ...

Thirty years on, miRNA-based diagnostic and therapeutic agents for HCC remain a work-in-progress (WIP) and no current miRNA HCC clinical trial has progressed to phase 4. The question remains why ...